CVR: 44226189
Loma Therapeutics ApS is a Danish company of the type Anpartsselskab based in København N, founded in 2023. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Ditte Rahbæk Boilesen and Stephanie Holstein-Rønsbo. The company is owned by Northgaard Holding ApS, Ditte Boilesen Holding ApS and Holstein-Rønsbo Holding ApS. In 2025, the company reported a gross profit of DKK -483,088 and a net result of DKK -3,540,377. Equity amounted to DKK -8,121,947.
Your company? Claim the profile and show your logo, website and social channels — for free.
Claim this profileSelskabets formål er at foretage forskning, udvikling og kommercialisering inden for medicinske produkter.
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringCompared to 1.037 companies in Forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Comparison is based on industry median values
Loma Therapeutics ApS has published its annual report for 2025. Gross profit came to DKK -483,088, and the net result was DKK -3,540,377.
As of May 22, 2026, RSM DANMARK STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of Loma Therapeutics ApS.
Loma Therapeutics ApS has published its interim report for the period August 9, 2023 – December 31, 2024.
As of January 13, 2025, Alejandra Maria Cristina Bonifacini Mørk has joined the board of directors of Loma Therapeutics ApS.
As of January 13, 2025, Leif Helth Jensen has joined the board of directors of Loma Therapeutics ApS.
As of January 13, 2025, Stuart John Myles Collinson has joined the board of directors of Loma Therapeutics ApS.
As of January 13, 2025, Ralf Wagner has joined the board of directors of Loma Therapeutics ApS.
As of January 13, 2025, Northgaard Holding ApS is registered as an owner of Loma Therapeutics ApS with an ownership share of 5%.
As of February 7, 2024, RSM DANMARK STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of Loma Therapeutics ApS.
As of February 7, 2024, Taastrup 2024 P/S has stepped down as auditor of Loma Therapeutics ApS.
As of August 9, 2023, Taastrup 2024 P/S has been appointed auditor of Loma Therapeutics ApS.
As of August 9, 2023, Ditte Rahbæk Boilesen is registered as director of Loma Therapeutics ApS.
As of August 9, 2023, Stephanie Holstein-Rønsbo is registered as director of Loma Therapeutics ApS.
As of August 9, 2023, Ditte Boilesen Holding ApS is registered as an owner of Loma Therapeutics ApS with an ownership share of 33%.
As of August 9, 2023, Holstein-Rønsbo Holding ApS is registered as an owner of Loma Therapeutics ApS with an ownership share of 33%.
Loma Therapeutics ApS was founded on August 9, 2023.
Companies in the same industry and area
CVR 45436497
CVR 46543912
CVR 43506242
CVR 40766383
CVR 42731323
companydata.dk